PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $275,000 | -58.6% | 36,800 | -66.9% | 0.01% | -64.3% |
| Q1 2015 | $664,000 | -23.1% | 111,100 | -2.7% | 0.01% | -30.0% |
| Q4 2014 | $864,000 | +45.7% | 114,232 | 0.0% | 0.02% | +33.3% |
| Q3 2014 | $593,000 | +20.5% | 114,232 | 0.0% | 0.02% | +15.4% |
| Q2 2014 | $492,000 | +59.2% | 114,232 | +51.2% | 0.01% | +44.4% |
| Q1 2014 | $309,000 | -19.9% | 75,532 | +4.3% | 0.01% | -25.0% |
| Q4 2013 | $386,000 | +6.3% | 72,400 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $363,000 | +12.4% | 72,400 | 0.0% | 0.01% | -7.7% |
| Q2 2013 | $323,000 | – | 72,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 1,255,000 | $5,823,000 | 1.12% |
| Phocas Financial Corp. | 1,146,292 | $5,319,000 | 0.54% |
| Worth Venture Partners, LLC | 138,357 | $641,000 | 0.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,293,179 | $10,640,000 | 0.34% |
| Monashee Investment Management LLC | 240,000 | $1,114,000 | 0.26% |
| BKS ADVISORS, LLC | 118,587 | $550,000 | 0.22% |
| PINNACLE ASSOCIATES LTD | 1,418,391 | $6,581,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,200,820 | $19,492,000 | 0.15% |
| Fosun International Ltd | 472,580 | $2,174,000 | 0.14% |
| CARILLON TOWER ADVISERS, INC. | 3,948,024 | $18,318,000 | 0.13% |